X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-11 | CTLT | Ryan Michelle R | Dir | S - Sale | $59.70 | -2,800 | 10,835 | -21% | -$167,160 | ||||||
2024-10-18 | CTLT | Ferraro Joseph Anthony | SVP, GC, CCO | S - Sale | $59.97 | -320 | 23,967 | -1% | -$19,190 | ||||||
2024-09-26 | CTLT | McErlane David | Group Pres, Biologics | S - Sale | $59.97 | -1,994 | 36,304 | -5% | -$119,580 | ||||||
2024-08-02 | CTLT | Hopson Ricky | Pres BioProduct Delivery, CoS | S - Sale | $59.56 | -662 | 29,974 | -2% | -$39,429 | ||||||
2024-08-02 | CTLT | Gunther Scott | SVP, Quality, Reg. Affairs | S - Sale | $59.55 | -666 | 39,635 | -2% | -$39,660 | ||||||
2024-08-02 | CTLT | Ferraro Joseph Anthony | SVP, GC, CCO | S - Sale | $59.58 | -608 | 24,287 | -2% | -$36,225 | ||||||
2024-08-02 | CTLT | Evoli Lisa | SVP, CHRO | S - Sale | $59.67 | -3,859 | 39,366 | -9% | -$230,267 | ||||||
2024-08-02 | CTLT | Gennadios Aristippos | Group Pres Pharma, Consumer | S - Sale | $59.55 | -1,169 | 113,724 | -1% | -$69,614 | ||||||
2024-07-29 | CTLT | Maselli Alessandro | Pres, CEO | S - Sale | $58.76 | -9,088 | 177,521 | -5% | -$534,011 | ||||||
2024-07-29 | CTLT | Hopson Ricky | Pres BioProduct Delivery, CoS | S - Sale | $58.67 | -206 | 30,636 | -1% | -$12,086 | ||||||
2024-07-29 | CTLT | Gunther Scott | SVP, Quality, Reg. Affairs | S - Sale | $58.69 | -283 | 40,301 | -1% | -$16,609 | ||||||
2024-07-29 | CTLT | Gennadios Aristippos | Group Pres Pharma, Consumer | S - Sale | $58.70 | -349 | 114,893 | 0% | -$20,486 | ||||||
2024-07-08 | CTLT | Masanovich Matti | SVP, CFO | S - Sale | $56.74 | -2,993 | 33,871 | -8% | -$169,823 | ||||||
2024-06-04 | CTLT | Hopson Ricky | Pres BioProduct Delivery, CoS | S - Sale | $54.26 | -1,401 | 20,617 | -6% | -$76,023 | ||||||
2024-03-15 | CTLT | Gunther Scott | SVP, Quality, Reg. Affairs | S - Sale | $56.20 | -387 | 29,506 | -1% | -$21,749 | ||||||
2023-08-31 | CTLT | Ryan Michelle R | Dir | P - Purchase | $49.98 | +1,000 | 1,979 | +102% | +$49,980 | ||||||
| D | 2023-08-30 | CTLT | Greisch John J | Exec Chair | P - Purchase | $50.24 | +21,000 | 50,196 | +72% | +$1,055,040 | |||||
2023-08-24 | CTLT | Maselli Alessandro | Pres, CEO | S - Sale | $44.54 | -2,071 | 88,004 | -2% | -$92,245 | ||||||
2023-08-24 | CTLT | Gunther Scott | SVP, Quality, Reg. Affairs | S - Sale | $44.57 | -269 | 29,932 | -1% | -$11,989 | ||||||
2023-08-24 | CTLT | Grippo Michael J | SVP, Strategy, Corp. Dev. | S - Sale | $44.50 | -390 | 24,449 | -2% | -$17,355 | ||||||
2023-08-24 | CTLT | Gennadios Aristippos | Group Pres Pharma, Consumer | S - Sale | $44.49 | -396 | 96,552 | 0% | -$17,618 | ||||||
2023-08-24 | CTLT | Fasman Steven L | EVP, Chief Admin Officer | S - Sale | $44.65 | -817 | 73,789 | -1% | -$36,479 | ||||||
2023-08-24 | CTLT | Carletti Lorenzo | SVP Global Ops Ph, Cons Hlth | S - Sale | $44.71 | -216 | 8,746 | -2% | -$9,657 | ||||||
2023-08-24 | CTLT | Arnold Jonathan | SVP, CCO, Div. Head BioP Del. | S - Sale | $44.87 | -87 | 57,399 | 0% | -$3,904 | ||||||
2023-08-24 | CTLT | Hopson Ricky | Pres Clinical Dev Supply Div | S - Sale | $44.56 | -276 | 22,040 | -1% | -$12,299 | ||||||
2023-08-24 | CTLT | Hawkeswood Thomas W | Pres Pharma Prod Delivery Div | S - Sale | $44.72 | -147 | 7,533 | -2% | -$6,574 | ||||||
2023-08-24 | CTLT | Lickfold Charles | SVP, CIO | S - Sale | $44.72 | -190 | 11,339 | -2% | -$8,497 | ||||||
2023-08-24 | CTLT | Hunt Patricia | Pres Consumer Health Div | S - Sale | $44.77 | -106 | 11,289 | -1% | -$4,746 | ||||||
2023-08-24 | CTLT | Pravda Ricardo | Chief Transformation Officer | S - Sale | $44.47 | -379 | 30,224 | -1% | -$16,854 | ||||||
2023-08-01 | CTLT | Pravda Ricardo | Chief Transformation Officer | S - Sale | $47.56 | -269 | 29,522 | -1% | -$12,793 | ||||||
2023-08-01 | CTLT | Maselli Alessandro | Pres, CEO | S - Sale | $47.13 | -1,485 | 86,101 | -2% | -$69,995 | ||||||
| D | 2023-08-01 | CTLT | Lickfold Charles | SVP, CIO | S - Sale+OE | $47.90 | -135 | 10,892 | -1% | -$6,467 | |||||
| D | 2023-08-01 | CTLT | Hunt Patricia | Pres Consumer Health Div | S - Sale+OE | $47.95 | -161 | 11,106 | -1% | -$7,720 | |||||
| D | 2023-08-01 | CTLT | Hopson Ricky | Pres Clinical Dev Supply Div | S - Sale+OE | $47.86 | -195 | 21,047 | -1% | -$9,333 | |||||
| D | 2023-08-01 | CTLT | Hawkeswood Thomas W | Pres Pharma Prod Delivery Div | S - Sale+OE | $47.97 | -258 | 7,412 | -3% | -$12,376 | |||||
| D | 2023-08-01 | CTLT | Gunther Scott | SVP, Quality, Reg. Affairs | S - Sale+OE | $47.90 | -190 | 29,120 | -1% | -$9,101 | |||||
| D | 2023-08-01 | CTLT | Grippo Michael J | SVP, Strategy, Corp. Dev. | S - Sale+OE | $47.72 | -276 | 23,725 | -1% | -$13,171 | |||||
| D | 2023-08-01 | CTLT | Gennadios Aristippos | Group Pres Pharma, Consumer | S - Sale+OE | $47.59 | -281 | 95,358 | 0% | -$13,373 | |||||
| D | 2023-08-01 | CTLT | Carletti Lorenzo | SVP Global Ops Ph, Cons Hlth | S - Sale+OE | $47.77 | -383 | 8,505 | -4% | -$18,296 | |||||
2023-08-01 | CTLT | Arnold Jonathan | SVP, CCO, Div. Head BioP Del. | S - Sale | $47.80 | -62 | 55,896 | 0% | -$2,964 | ||||||
| D | 2023-08-01 | CTLT | Fasman Steven L | EVP, Chief Admin Officer | S - Sale+OE | $47.05 | -1,637 | 72,101 | -2% | -$77,026 | |||||
2023-05-01 | CTLT | Boerman Manja | Pres BioModalities Division | S - Sale | $49.86 | -1,446 | 14,414 | -9% | -$72,098 | ||||||
2023-05-01 | CTLT | Gargiulo Mario | SVP, Ops, Biologics Europe | S - Sale | $49.86 | -678 | 5,676 | -11% | -$33,805 | ||||||
2023-01-23 | CTLT | Hopson Ricky | Pres Clinical Dev Supply Div | S - Sale | $49.36 | -643 | 16,452 | -4% | -$31,738 | ||||||
2022-12-05 | CTLT | Boerman Manja | Pres BioModalities Division | S - Sale | $51.70 | -780 | 15,860 | -5% | -$40,326 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |